GH001
GH Research Reports Positive Phase 2b Results for Inhaled 5-MeO-DMT in Treatment-Resistant Depression
GH Research, 5-MeO-DMT, GH001, treatment-resistant depression, psychedelic therapy, clinical trial, Phase 2b
Actionable Insights Powered by AI
GH Research, 5-MeO-DMT, GH001, treatment-resistant depression, psychedelic therapy, clinical trial, Phase 2b